Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$2,383,534
+$293,238 QoQ
Shares Held
9,472
-1.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#1,827
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRAPHAGEN INVESTMENT ADVISORS LLC holds $8,468,712 across 7 Drug Manufacturers - General names. ABBV ranks #2 (28.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,821 | $2,494,239 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
9,472 | $2,383,534 | |
| 3 | LLY |
ELI LILLY & Co
|
1,286 | $1,542,467 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,280 | $806,980 | |
| 5 | PFE |
Pfizer Inc
|
22,620 | $544,689 | |
| 6 | AMGN |
Amgen Inc
|
1,367 | $495,018 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,502 | $201,785 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,383,534 | 9,472 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,090,296 | 9,611 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $2,205,156 | 9,651 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $2,231,119 | 9,636 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $1,786,778 | 9,626 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $2,018,725 | 9,635 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $1,723,512 | 9,699 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,914,371 | 9,694 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,674,549 | 9,763 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $1,788,768 | 9,823 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,507,083 | 9,725 | Shares | Sole | 2024-06-17 | |
| 2023-09-30 | $1,464,961 | 9,828 | Shares | Sole | 2024-06-17 | |
| 2023-06-30 | $1,323,452 | 9,823 | Shares | Sole | 2024-06-17 | |
| 2023-03-31 | $757,326 | 4,752 | Shares | Sole | 2024-06-17 | |
| 2022-12-31 | $721,588 | 4,465 | Shares | Sole | 2024-06-17 | |
| 2022-09-30 | $460,742 | 3,433 | Shares | Sole | 2024-06-17 | |
| 2022-06-30 | $525,798 | 3,433 | Shares | Sole | 2024-06-17 | |
| 2022-03-31 | $556,523 | 3,433 | Shares | Sole | 2024-06-17 | |
| 2021-12-31 | $803,192 | 5,932 | Shares | Sole | 2024-06-17 | |
| 2021-09-30 | $633,089 | 5,869 | Shares | Sole | 2024-06-17 | |
| 2021-06-30 | $656,578 | 5,829 | Shares | Sole | 2024-06-17 | |
| 2021-03-31 | $599,647 | 5,541 | Shares | Sole | 2024-06-17 | |
| 2020-12-31 | $593,289 | 5,537 | Shares | Sole | 2024-06-17 | |
| 2020-09-30 | $490,066 | 5,595 | Shares | Sole | 2024-06-17 | |
| 2020-06-30 | $510,830 | 5,203 | Shares | Sole | 2024-06-17 | |
| 2020-03-31 | $392,530 | 5,152 | Shares | Sole | 2024-06-17 | |
| No filing history on record for this holder in this stock. | ||||||